CRBU
Price
$1.94
Change
+$0.08 (+4.30%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
173.85M
102 days until earnings call
Intraday BUY SELL Signals
NKTX
Price
$1.84
Change
+$0.07 (+3.93%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
126.43M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs NKTX

Header iconCRBU vs NKTX Comparison
Open Charts CRBU vs NKTXBanner chart's image
Caribou Biosciences
Price$1.94
Change+$0.08 (+4.30%)
Volume$6.28K
Capitalization173.85M
Nkarta
Price$1.84
Change+$0.07 (+3.93%)
Volume$18.81K
Capitalization126.43M
CRBU vs NKTX Comparison Chart in %
CRBU
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBU vs. NKTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CRBU: $1.86 vs. NKTX: $1.78)
Brand notoriety: CRBU and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 29% vs. NKTX: 64%
Market capitalization -- CRBU: $173.85M vs. NKTX: $126.43M
CRBU [@Biotechnology] is valued at $173.85M. NKTX’s [@Biotechnology] market capitalization is $126.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 5 bearish.
  • NKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -1.06% price change this week, while NKTX (@Biotechnology) price change was -2.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 16, 2026.

NKTX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($174M) has a higher market cap than NKTX($126M). CRBU YTD gains are higher at: 16.981 vs. NKTX (-28.514). NKTX has higher annual earnings (EBITDA): -119.2M vs. CRBU (-150.76M). NKTX has more cash in the bank: 290M vs. CRBU (184M). CRBU has less debt than NKTX: CRBU (25.9M) vs NKTX (78.5M). CRBU has higher revenues than NKTX: CRBU (9.12M) vs NKTX (0).
CRBUNKTXCRBU / NKTX
Capitalization174M126M138%
EBITDA-150.76M-119.2M126%
Gain YTD16.981-28.514-60%
P/E RatioN/AN/A-
Revenue9.12M0-
Total Cash184M290M63%
Total Debt25.9M78.5M33%
TECHNICAL ANALYSIS
Technical Analysis
CRBUNKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINN14375.010.01
N/A
First National of Nebraska, Inc.
IHICF20.25N/A
N/A
IHI Corp
MNMB39.10N/A
N/A
Merchants & Marine Bancorp Inc.
PRRCF9.29N/A
N/A
Procredit Holding Ag
SENR0.05N/A
N/A
Strategic Environmental & Energy Resources, Inc.

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+2.30%
SYRE - NKTX
50%
Loosely correlated
+13.38%
BEAM - NKTX
50%
Loosely correlated
+14.42%
CRBU - NKTX
46%
Loosely correlated
+5.68%
FATE - NKTX
45%
Loosely correlated
+7.46%
DNLI - NKTX
45%
Loosely correlated
+6.50%
More